Business Context and Reporting Period
This Form 8-K filing by Molina Healthcare, Inc. reports on executive compensation adjustments effective for the fiscal year 2011. The report date is February 16, 2011, detailing decisions made by the Compensation Committee regarding base salaries, bonus structures, and equity grants for the CEO, CFO, and COO.
Key Financial Metrics and Compensation Details
The filing outlines specific compensation targets and thresholds rather than historical financial performance metrics.
- CEO (Dr. J. Mario Molina): Base salary increased to $935,000; bonus opportunity set at 120% of base ($1,122,000); granted 100,000 shares of restricted stock.
- CFO (John Molina): Base salary increased to $852,500; bonus opportunity set at 100% of base ($852,500); granted 75,000 shares of restricted stock.
- COO (Terry Bayer): Base salary increased to $625,000; bonus opportunity set at 85% of base ($531,250); granted 18,000 shares of restricted stock.
- Performance Thresholds: Executive bonuses are tied to Fiscal Year 2011 EBITDA. The threshold for any bonus payout is $187 million, with target and maximum levels set at $202 million and $232 million, respectively.
- Equity Vesting Condition: Restricted stock grants vest on March 1, 2012, contingent upon the company achieving total operating revenue of at least $3,678,000,000 in 2011.
Material Changes Versus Prior Period
The filing details significant increases in base compensation for the three named executive officers compared to their prior fiscal year levels:
- CEO base salary increased from $850,000 to $935,000.
- CFO base salary increased from $775,000 to $852,500.
- COO base salary increased from $500,000 to $625,000.
Additionally, the company established new bonus opportunity levels and performance measures for 2011, shifting focus to EBITDA as the primary metric for cash bonuses.
Guidance, Outlook, and Risks
The filing does not provide general business guidance or outlook beyond the specific financial targets required for executive compensation.
- Compensation Risks: Executive bonuses are capped at 125% of the opportunity level and require a minimum EBITDA of $187 million to trigger any payout. Equity awards will lapse if the revenue target of $3.678 billion is not met or if the officers are not employed as of March 1, 2012.
- Discretionary Authority: The Compensation Committee retains the right to adjust bonus awards based on performance, subject to Internal Revenue Code Section 162(m) limitations.
Key Facts for Investor Verification
- Verify if the company's actual 2011 EBITDA met the $187 million threshold required for executive cash bonuses.
- Confirm whether total operating revenue for 2011 reached the $3.678 billion target necessary for the vesting of restricted stock grants.
- Review the 2011 annual proxy statement for full disclosure of the final compensation paid to named executive officers.
- Note that the filing does not contain audited financial statements or cash flow data for the period.